Search research articles
Contact Us
Filters
Showing results (921-930 of 940) with videos related to
Page
of 94
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
August 4, 2025
Pelota-mediated ribosome-associated quality control counteracts aging and age-associated pathologies across species
Jongsun Lee, Bora Lee, Hyein Lee, et al.
Breast Cancer Research : BCR
|
September 13, 2014
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase
Xiaoyong Fu, Chad J Creighton, Nrusingh C Biswal, et al.
Cancer Letters
|
March 14, 2026
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence and chemotherapy resistance in cancer
Santiago Panesso-Gómez, Alexander J Cole, Austin Arrigo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X Ma, Feng Gao, Jingqin Luo, et al.
Cancer Cell
|
April 17, 2026
Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression
Triet Minh Bui, Ernesto Rojas Jimenez, Zheqi Li, et al.
NPJ Breast Cancer
|
February 20, 2026
Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programs
Gitte Zels, Karen Van Baelen, Alexander Cc Chang, et al.
Nature Cancer
|
June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacy
Dong Hu, Xiaoshuang Lyu, Zheqi Li, et al.
Cancer Cell
|
May 8, 2026
Whole-genome doubling drives immune evasion by silencing antigen presentation
Pierre Foidart, Zheqi Li, Xinran Cai, et al.
Breast Cancer Research : BCR
|
June 19, 2025
Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer
Alexander Chih-Chieh Chang, Marija Balic, Tanner Bartholow, et al.
Biorxiv : the Preprint Server for Biology
|
November 22, 2024
Hope for Others: Research Results from the University of Pittsburgh Rapid Autopsy Program for Breast Cancer
Alexander Chih-Chieh Chang, Marija Balic, Tanner Bartholow, et al.
Page
of 94
Search research articles
Search
Showing results (921-930 of 940) with videos related to
Sort By:
Page
of 94
Proceedings of the National Academy of Sciences of the United States of America
|
August 4, 2025
Pelota-mediated ribosome-associated quality control counteracts aging and age-associated pathologies across species
Jongsun Lee, Bora Lee, Hyein Lee, et al.
Breast Cancer Research : BCR
|
September 13, 2014
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase
Xiaoyong Fu, Chad J Creighton, Nrusingh C Biswal, et al.
Cancer Letters
|
March 14, 2026
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence and chemotherapy resistance in cancer
Santiago Panesso-Gómez, Alexander J Cole, Austin Arrigo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X Ma, Feng Gao, Jingqin Luo, et al.
Cancer Cell
|
April 17, 2026
Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression
Triet Minh Bui, Ernesto Rojas Jimenez, Zheqi Li, et al.
NPJ Breast Cancer
|
February 20, 2026
Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programs
Gitte Zels, Karen Van Baelen, Alexander Cc Chang, et al.
Nature Cancer
|
June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacy
Dong Hu, Xiaoshuang Lyu, Zheqi Li, et al.
Cancer Cell
|
May 8, 2026
Whole-genome doubling drives immune evasion by silencing antigen presentation
Pierre Foidart, Zheqi Li, Xinran Cai, et al.
Breast Cancer Research : BCR
|
June 19, 2025
Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer
Alexander Chih-Chieh Chang, Marija Balic, Tanner Bartholow, et al.
Biorxiv : the Preprint Server for Biology
|
November 22, 2024
Hope for Others: Research Results from the University of Pittsburgh Rapid Autopsy Program for Breast Cancer
Alexander Chih-Chieh Chang, Marija Balic, Tanner Bartholow, et al.
Page
of 94